Symbol="ABUS"
AssetType="Common Stock"
Name="Arbutus Biopharma Corp"
Description="Arbutus Biopharma Corporation, a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of a cure for patients with chronic hepatitis B virus (HBV) infection in the United States. The company is headquartered in Warminster, Pennsylvania."
CIK="1447028"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="100-8900 GLENLYON PARKWAY, BURNABY, BC, CA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="370479000"
EBITDA="-68223000"
PERatio="None"
PEGRatio="0"
BookValue="0.872"
DividendPerShare="0"
DividendYield="0"
EPS="-0.45"
RevenuePerShareTTM="0.215"
ProfitMargin="-2.114"
OperatingMarginTTM="-2.101"
ReturnOnAssetsTTM="-0.203"
ReturnOnEquityTTM="-0.452"
RevenueTTM="33125000"
GrossProfitTTM="-45389000"
DilutedEPSTTM="-0.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.468"
AnalystTargetPrice="5.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.68"
PriceToBookRatio="2.806"
EVToRevenue="7.67"
EVToEBITDA="-4.533"
Beta="2.115"
num_52WeekHigh="3.15"
num_52WeekLow="1.85"
num_50DayMovingAverage="2.427"
num_200DayMovingAverage="2.581"
SharesOutstanding="166134000"
DividendDate="None"
ExDividendDate="None"
symbol="ABUS"
open="2.27"
high="2.27"
low="2.15"
price="2.17"
volume="696398.00"
latest_trading_day="2023-07-21"
previous_close="2.25"
change="-0.08"
change_percent="-3.5556%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="61"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="39"
Volume_recent_avg="783846"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="39"
Aroon_momentum_negative="61"
image_negative_thumbnail_id_1="1131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_negative_thumbnail_id_2="116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0060.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="961"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0123.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
